Evidence map›Paper›PMID 33762628›Full record

ArticleScientific reports2021

Comparative in silico genome analysis of Clostridium perfringens unravels stable phylogroups with different genome characteristics and pathogenic potential.

Mostafa Y Abdel-Glil, Prasad Thomas, Jörg Linde, Anne Busch, Lothar H Wieler, Heinrich Neubauer, Christian Seyboldt

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.4field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Genomic and clinical determinants of extraintestinalmedRxiv : the preprint server for health sciences · 2026
    Article
  5. Article
  6. Genetic characterization of gut-associatedFrontiers in microbiology · 2026
    Article
  7. Sporulation Abilities and Heat Resistance ofFoods (Basel, Switzerland) · 2025
    Article
  8. Article
  9. Article
  10. First genomic analysis of aFrontiers in microbiology · 2025
    Article
  11. Isolation of a VirulentCurrent issues in molecular biology · 2024
    Article
  12. Identification of a newFrontiers in microbiology · 2024
    Article
  13. Types A and FApplied and environmental microbiology · 2023
    Article
  14. Journal of advanced veterinary and animal research · 2023
    Article
  15. Pathogens (Basel, Switzerland) · 2023
    Review
  16. Article
  17. Article
  18. Review
  19. Intra-species diversity ofFrontiers in microbiology · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

Mostafa Y Abdel-GlilInstitute of Bacterial Infections and Zoonoses, Friedrich-Loeffler-Institut, Naumburger Str. 96A, 07743, Jena, Germany. mostafa.abdelglil@fli.de.
Prasad ThomasInstitute of Bacterial Infections and Zoonoses, Friedrich-Loeffler-Institut, Naumburger Str. 96A, 07743, Jena, Germany.
Jörg LindeInstitute of Bacterial Infections and Zoonoses, Friedrich-Loeffler-Institut, Naumburger Str. 96A, 07743, Jena, Germany.
Anne BuschInstitute of Bacterial Infections and Zoonoses, Friedrich-Loeffler-Institut, Naumburger Str. 96A, 07743, Jena, Germany.
Lothar H WielerRobert Koch-Institut, Nordufer 20, 13353, Berlin, Germany.
Heinrich NeubauerInstitute of Bacterial Infections and Zoonoses, Friedrich-Loeffler-Institut, Naumburger Str. 96A, 07743, Jena, Germany.
Christian SeyboldtInstitute of Bacterial Infections and Zoonoses, Friedrich-Loeffler-Institut, Naumburger Str. 96A, 07743, Jena, Germany. christian.seyboldt@fli.de.
Friedrich-Loeffler-Institut · DEIndian Veterinary Research Institute · INJena University Hospital · DERobert Koch Institute · DEZagazig University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clostridium perfringens causes a plethora of devastating infections, with toxin production being the underlying mechanism of pathogenicity in various hosts. Genomic analyses of 206 public-available C. perfringens strains´ sequence data identified a substantial degree of genomic variability in respect to episome content, chromosome size and mobile elements. However, the position and order of the local collinear blocks on the chromosome showed a considerable degree of preservation. The strains were divided into five stable phylogroups (I-V). Phylogroup I contained human food poisoning strains with chromosomal enterotoxin (cpe) and a Darmbrand strain characterized by a high frequency of mobile elements, a relatively small genome size and a marked loss of chromosomal genes, including loss of genes encoding virulence traits. These features might correspond to the adaptation of these strains to a particular habitat, causing human foodborne illnesses. This contrasts strains that belong to phylogroup II where the genome size points to the acquisition of genetic material. Most strains of phylogroup II have been isolated from enteric lesions in horses and dogs. Phylogroups III, IV and V are heterogeneous groups containing a variety of different strains, with phylogroup III being the most abundant (65.5%). In conclusion, C. perfringens displays five stable phylogroups reflecting different disease involvements, prompting further studies on the evolution of this highly important pathogen.

Indexed as

Genome, BacterialGenomicsPhylogenyChromosomes, BacterialClostridium InfectionsClostridium perfringensComputational BiologyDNA Transposable ElementsGenome-Wide Association StudyMultigene FamilyPolymorphism, Single NucleotideVirulenceVirulence FactorsDNA Transposable ElementsVirulence Factors

Identifiers

PMID33762628
PMCPMC7991664
OpenAlexW3138256547

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.